Persistent Sleep Quality Deterioration among Post-COVID-19 Patients: Results from a 6-Month Follow-Up Study.
Pittsburgh sleep quality index
SARS-CoV-2
insomnia
post-COVID-19
sleep quality
Journal
Journal of personalized medicine
ISSN: 2075-4426
Titre abrégé: J Pers Med
Pays: Switzerland
ID NLM: 101602269
Informations de publication
Date de publication:
16 Nov 2022
16 Nov 2022
Historique:
received:
18
10
2022
revised:
13
11
2022
accepted:
14
11
2022
entrez:
24
11
2022
pubmed:
25
11
2022
medline:
25
11
2022
Statut:
epublish
Résumé
Background: To date, evidence about sleep disturbances among post-COVID-19 patients is limited. This study aimed to evaluate sleep quality after hospitalization due to SARS-CoV-2 infection. Methods: In-person follow-up was conducted in patients with prior hospitalization due to COVID-19 1(Τ1), 3(Τ2), and 6 (Τ3) months after hospital discharge. Patients were asked to complete questionnaires concerning sleep quality: the Pittsburgh Sleep Quality Index (PSQI), the Epworth Sleepiness Scale (ESS), the Athens Insomnia Scale (AIS), the Fatigue Severity Scale (FSS), and the Stop-BANG (S-B) questionnaire. Results: In total, 133 patients were enrolled (mean age: 56.0 ± 11.48 years, 59.4% males). The most frequently reported comorbidity was arterial hypertension (29.8% of patients), while 37.4% of patients had no comorbidities. The majority of participants exhibited poor sleep quality (global PSQI ≥ 5) at T1 (84.3%), T2 (75.7%), and T3 (77.4%). Insomnia was observed in 56.5%, 53.5%, and 39.2% of participants, respectively (AIS ≥ 6). An FSS score ≥ 4 was observed in 51.2%, 33.7%, and 29.1% of participants at T1, T2, T3, respectively. Elapsed time was found to be negatively and independently associated with the global PSQI, PSQI C5-Sleep disturbance, PSQI C7-Daytime dysfunctions, FSS, and AIS after adjustment for possible confounders. No significant difference was found between groups with good and poor sleep quality (based on the global PSQI) with respect to gender (p = 0.110), age (p = 0.528), BMI (p = 0.816), smoking status (p = 0.489), hypertension (p = 0.427), severity of disease (p = 0.224), the Charlson Comorbidity Index (p = 0.827), or the length of hospital stay (p = 0.162). Participants with excessive daytime sleepiness (EDS) and patients with severe fatigue (FSS ≥ 4) were significantly younger. Females presented a higher rate of insomnia symptoms (55.7% vs. 44.3%, p < 0.001). Conclusions: Several sleep disturbances were observed after hospital discharge for COVID-19 pneumonia at certain time points; However, the improvement over time was remarkable in most domains of the assessed questionnaires.
Identifiants
pubmed: 36422085
pii: jpm12111909
doi: 10.3390/jpm12111909
pmc: PMC9692708
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
J Sleep Res. 2020 Aug;29(4):e13074
pubmed: 32410272
Lancet Psychiatry. 2021 May;8(5):416-427
pubmed: 33836148
Nat Commun. 2021 Nov 12;12(1):6571
pubmed: 34772922
J Clin Sleep Med. 2021 Feb 1;17(2):299-313
pubmed: 33108269
J Med Virol. 2022 Mar;94(3):971-978
pubmed: 34647638
Clin Exp Neuroimmunol. 2022 Feb;13(1):17-23
pubmed: 34899999
Int J Environ Res Public Health. 2020 Jul 02;17(13):
pubmed: 32630821
Lancet Psychiatry. 2020 Jul;7(7):611-627
pubmed: 32437679
EClinicalMedicine. 2021 Jun;36:100916
pubmed: 34131640
Sci Rep. 2018 Jul 23;8(1):11052
pubmed: 30038272
BMJ. 2021 Jan 22;372:n136
pubmed: 33483331
Psychosom Med. 2007 Nov;69(8):756-61
pubmed: 17942834
J Clin Sleep Med. 2020 Jul 15;16(7):1215
pubmed: 32323647
Cureus. 2021 Sep 22;13(9):e18182
pubmed: 34722016
Sleep. 2006 Oct;29(10):1347-52
pubmed: 17068989
Chronobiol Int. 2020 May;37(5):607-617
pubmed: 32432519
Brain Behav Immun. 2020 Aug;88:17-27
pubmed: 32416290
Braz J Psychiatry. 2020;42(3):232-235
pubmed: 32267343
Sleep Med Clin. 2008;3(2):281-293
pubmed: 19122865
Healthcare (Basel). 2021 May 13;9(5):
pubmed: 34068009
Sleep. 2008 Nov;31(11):1601-7
pubmed: 19014080
J Sleep Res. 2016 Apr;25(2):131-43
pubmed: 26762182
Lancet. 2021 Jan 16;397(10270):220-232
pubmed: 33428867
J Clin Sleep Med. 2018 Aug 15;14(8):1293-1301
pubmed: 30092893
Egypt J Neurol Psychiatr Neurosurg. 2021;57(1):172
pubmed: 34924750
J Pers Med. 2021 Nov 14;11(11):
pubmed: 34834555
Ther Adv Infect Dis. 2021 Apr 20;8:20499361211009385
pubmed: 33959278
J Gerontol A Biol Sci Med Sci. 2005 Jan;60(1):104-8
pubmed: 15741291
Curr Biol. 2013 Aug 19;23(16):1554-8
pubmed: 23910656
Brain Behav Immun. 2020 Oct;89:594-600
pubmed: 32738287
Nat Sci Sleep. 2021 Jun 28;13:933-966
pubmed: 34234598
Brain Behav Immun. 2009 Mar;23(3):351-4
pubmed: 19007876
Brain Behav Immun. 2020 Aug;88:11-16
pubmed: 32416289
Curr Opin Pulm Med. 2006 Nov;12(6):383-9
pubmed: 17053485
J Psychosom Res. 1998 Jul;45(1):5-13
pubmed: 9720850
Sleep Sci. 2014 Dec;7(4):234-7
pubmed: 26483934
Chest. 2016 Mar;149(3):631-8
pubmed: 26378880
J Psychosom Res. 2003 Sep;55(3):263-7
pubmed: 12932801